Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Autoimmune Disorders

  Free Subscription


Articles published in Curr Opin Immunol

Retrieve available abstracts of 61 articles:
HTML format



Single Articles


    July 2026
  1. MOUTSOPOULOS HM
    The epithelial cell in Sjogren's syndrome: from passive target to orchestrator of autoimmune reactivity.
    Curr Opin Immunol. 2026;102:102815.
    PubMed     Abstract available


  2. LERNER A, Benzvi C
    The food additive microbial transglutaminase is a potential new environmental inducer of autoimmune diseases.
    Curr Opin Immunol. 2026;101:102812.
    PubMed     Abstract available


    June 2026
  3. MOUTSOPOULOS HM, Cinoku II, Mavragani CP
    Raynaud's phenomenon: a vascular or an autoimmune-mediated disorder? Facts and fancy.
    Curr Opin Immunol. 2026;101:102803.
    PubMed     Abstract available


  4. TONUTTI A, D'Amico S, Timilsina S, Gershwin ME, et al
    Use of synthetic data, a novel paradigm for immunopathology.
    Curr Opin Immunol. 2026;100:102753.
    PubMed     Abstract available


  5. PERICLEOUS C, Strauss E, Arachchillage DJ
    Endothelial dysfunction in APS: advancing pathophysiological understanding to improve management.
    Curr Opin Immunol. 2026;100:102745.
    PubMed     Abstract available


    May 2026
  6. CAMERA M, Tremoli E, Lonati PA, Meroni PL, et al
    Novel mechanisms linking platelet activation to antiphospholipid syndrome.
    Curr Opin Immunol. 2026;101:102791.
    PubMed     Abstract available


  7. ARACHCHILLAGE DJ, Efthymiou M, Cohen H
    The role of different aPL subpopulations in the lupus anticoagulant phenomenon.
    Curr Opin Immunol. 2026;100:102784.
    PubMed     Abstract available


    April 2026
  8. SURESH SC, Furie R, Narain S
    Outcome measures in systemic lupus erythematosus.
    Curr Opin Immunol. 2026;100:102782.
    PubMed     Abstract available


  9. SEVIM E, Erton ZB, Erkan D
    Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.
    Curr Opin Immunol. 2026;100:102770.
    PubMed     Abstract available


  10. FUJIEDA Y, Amengual O, Meroni PL, Atsumi T, et al
    Hot topics in the antiphospholipid syndrome.
    Curr Opin Immunol. 2026;100:102775.
    PubMed     Abstract available


  11. KIROU KA, Kirou RA, Flouda S
    New developments and future directions in the management of systemic lupus erythematosus.
    Curr Opin Immunol. 2026;100:102774.
    PubMed     Abstract available


  12. MARTINEZ T, Grand Z, Garcia S, Rockwell M, et al
    A global perspective on autoimmunity and immunodeficiency: exploring geoepidemiology trends.
    Curr Opin Immunol. 2026;100:102773.
    PubMed     Abstract available


  13. KUMAR S, Ponzar N, Pozzi N
    beta(2)-Glycoprotein I: structure, mechanisms of autoantibody recognition, and polymorphisms.
    Curr Opin Immunol. 2026;100:102771.
    PubMed     Abstract available


  14. KIRINO Y, Takeno M
    A critical look at animal and cellular models in autoinflammatory diseases.
    Curr Opin Immunol. 2026;99:102719.
    PubMed     Abstract available


    March 2026
  15. MATHEOUD D, Akbar I, Hercun J, Stratton JA, et al
    A liver-mitochondria-immune axis in Parkinson's disease: emerging perspectives on a hepatic origin for mitochondrial autoimmunity as a driver of Parkinson's disease.
    Curr Opin Immunol. 2026;100:102761.
    PubMed     Abstract available


  16. YALAVARTHI S, NaveenKumar SK, Knight JS
    Neutrophils and monocytes in the pathogenesis of antiphospholipid syndrome.
    Curr Opin Immunol. 2026;100:102768.
    PubMed     Abstract available


  17. RENAUDINEAU Y, Brooks W
    P2 purinergic receptors in systemic lupus erythematosus: from experimental findings to therapeutic perspectives.
    Curr Opin Immunol. 2026;100:102752.
    PubMed     Abstract available


  18. GROSSI C, Buckle II, McDonnell TC
    Autoimmunity beyond antibodies: alternative roles of beta-2-glycoprotein I in and out of antiphospholipid syndrome?
    Curr Opin Immunol. 2026;100:102748.
    PubMed     Abstract available


    February 2026
  19. JULIAN VELASCO-LANCHEROS O, Acosta-Ampudia Y, Monsalve DM, Ramirez-Santana C, et al
    Mpox virus immunology: exploring links to autoimmune diseases.
    Curr Opin Immunol. 2026;99:102744.
    PubMed     Abstract available


  20. ALTINTAS A, Bulus E
    Multiple sclerosis: a disease or a syndrome?
    Curr Opin Immunol. 2026;99:102736.
    PubMed     Abstract available


  21. MEGHASHYAM S, Serajee FJ, Prakash AV, Altinok D, et al
    Primary angiitis of the central nervous system.
    Curr Opin Immunol. 2026;98:102691.
    PubMed     Abstract available


    January 2026
  22. ELSAGHIR A, Witte T
    New autoantibodies in Sjogren's disease.
    Curr Opin Immunol. 2026;99:102722.
    PubMed     Abstract available


    December 2025
  23. YANG T, Goudarzi N, Kroese FGM, Mariette X, et al
    Salivary gland organoids and the future of modeling autoimmune epithelitis in Sjogren's disease.
    Curr Opin Immunol. 2025;98:102707.
    PubMed     Abstract available


    November 2025
  24. SWEENEY N, Atisha-Fregoso Y, Pozovskiy R, Higdon L, et al
    Can we cure autoimmunity?
    Curr Opin Immunol. 2025;98:102684.
    PubMed     Abstract available


    October 2025
  25. ROJAS M, Acosta-Ampudia Y, Monsalve DM, Rami?rez-Santana C, et al
    Autoimmunity, epitope analysis, and molecular mimicry.
    Curr Opin Immunol. 2025;97:102681.
    PubMed     Abstract available


  26. CLEMENT TL, Cohen PL
    Can we cure lupus?
    Curr Opin Immunol. 2025;96:102640.
    PubMed     Abstract available


  27. MAHARAJ S, Chang C
    Can juvenile idiopathic arthritis be cured?
    Curr Opin Immunol. 2025;96:102632.
    PubMed     Abstract available


  28. SULLIVAN JK, Kwun A, Jorgensen TN
    Neuropsychiatric lupus: a myriad of symptoms requires a myriad of models.
    Curr Opin Immunol. 2025;96:102631.
    PubMed     Abstract available


  29. FREE ME, Ciavatta DJ, Falk RJ
    Can we cure vasculitis?
    Curr Opin Immunol. 2025;96:102618.
    PubMed     Abstract available


    September 2025
  30. CLAVARINO G, Vigne J, Meuleman MS, Amen A, et al
    Complement in systemic lupus erythematosus across time and space: from tolerance to tissue injury and from extracellular to intracellular functions.
    Curr Opin Immunol. 2025;97:102655.
    PubMed     Abstract available


    August 2025
  31. MOSELEY CE, Sabatino JJ Jr, Zamvil SS
    B-cell antigen presentation in central nervous system autoimmunity.
    Curr Opin Immunol. 2025;96:102647.
    PubMed     Abstract available


  32. HU Z, Zhao M
    B cell-targeted therapies in autoimmune skin disease: current advances and challenges.
    Curr Opin Immunol. 2025;96:102643.
    PubMed     Abstract available


  33. DRAGON DUREY MA, Hamidi H, Darnige L
    Complement in antiphospholipid syndrome, time to target?
    Curr Opin Immunol. 2025;96:102628.
    PubMed     Abstract available


  34. MERONI PL, Capobianco E, Tedesco F
    Can we cure antiphospholipid syndrome?
    Curr Opin Immunol. 2025;96:102610.
    PubMed     Abstract available


  35. CETIN GEDIK K, Casares-Marfil D, Demirkaya E, Sawalha AH, et al
    The role of epigenetic modifications in systemic autoinflammatory diseases.
    Curr Opin Immunol. 2025;95:102599.
    PubMed     Abstract available


  36. XU C, Shen Y, Wang Q, Zhu H, et al
    Immunotherapy for pemphigus and bullous pemphigoid.
    Curr Opin Immunol. 2025;95:102591.
    PubMed     Abstract available


  37. LIU S, Lu Q
    Can we cure bullous skin diseases?
    Curr Opin Immunol. 2025;95:102589.
    PubMed     Abstract available


  38. OKAZAKI K, Ikeura T, Uchida K
    'Can we cure IgG4-related diseases?'.
    Curr Opin Immunol. 2025;95:102564.
    PubMed     Abstract available


    July 2025
  39. LIN SL, Carroll MC
    Neuroimmune mechanisms of neuropsychiatric systemic lupus erythematosus.
    Curr Opin Immunol. 2025;96:102608.
    PubMed     Abstract available


  40. LONGHI MS, Zhang L, Mieli-Vergani G, Vergani D, et al
    Can we cure autoimmune hepatitis?
    Curr Opin Immunol. 2025;96:102609.
    PubMed     Abstract available


  41. DEI ZOTTI F, Hudson KE
    Development and consequences of red blood cell autoantibodies: warm autoimmune hemolytic anemia.
    Curr Opin Immunol. 2025;95:102604.
    PubMed     Abstract available


  42. FAN S, Pruss H
    Pathogenic mechanisms of autoantibodies in neurological autoimmune diseases.
    Curr Opin Immunol. 2025;95:102594.
    PubMed     Abstract available


  43. XU Y, Yi X, Li C, Chen J, et al
    CD8(+)T cell exhaustion: the potential for treating autoimmune diseases.
    Curr Opin Immunol. 2025;95:102600.
    PubMed     Abstract available


    June 2025
  44. NIE W, Yang X, Ma M, Xu X, et al
    Chimeric antigen receptor T cell therapy for autoimmune diseases.
    Curr Opin Immunol. 2025;95:102596.
    PubMed     Abstract available


  45. DAI M, Mei B, Zheng F, Ballestar E, et al
    Sex hormones and epigenetic dysregulation in autoimmune disease.
    Curr Opin Immunol. 2025;95:102595.
    PubMed     Abstract available


  46. ZHOU W, Zhang B, Zhao M, Lu Q, et al
    Epigenetics: the link between environmental exposures and autoimmune diseases.
    Curr Opin Immunol. 2025;95:102592.
    PubMed     Abstract available


  47. MAUDES E, Planaguma J, Weber MS, Dalmau J, et al
    Animal models of autoimmune encephalitis.
    Curr Opin Immunol. 2025;95:102579.
    PubMed     Abstract available


  48. GUVENC F, Danska JS
    The intestinal microbiome in type 1 diabetes: bridging early childhood exposures with translational advances.
    Curr Opin Immunol. 2025;94:102553.
    PubMed     Abstract available


    May 2025
  49. CHEN J, Wang X
    Epigenetic regulation of B cell response in autoimmune diseases.
    Curr Opin Immunol. 2025;95:102582.
    PubMed     Abstract available


  50. LE PANSE R
    Is there a path to cure myasthenia gravis?
    Curr Opin Immunol. 2025;95:102577.
    PubMed     Abstract available


  51. KOLEV M, Kremer AE, Sokollik C, Gershwin ME, et al
    Unmet needs in autoimmune liver diseases.
    Curr Opin Immunol. 2025;95:102565.
    PubMed     Abstract available


    April 2025
  52. TAYLOR H, Uhlig HH, Powrie F
    Autoimmunity in inflammatory bowel disease: a holobiont perspective.
    Curr Opin Immunol. 2025;94:102557.
    PubMed     Abstract available


  53. SUN Y, Zhang Z, Jia K, Liu H, et al
    Autoimmune-related adverse events induced by immune checkpoint inhibitors.
    Curr Opin Immunol. 2025;94:102556.
    PubMed     Abstract available


  54. SAVVIDES CS, James EA, Buckner JH
    Rheumatoid arthritis - the role of T cells in this complex systemic autoimmune disease.
    Curr Opin Immunol. 2025;94:102555.
    PubMed     Abstract available


  55. WRIGHT RC, Campbell DJ, Levings MK
    Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity.
    Curr Opin Immunol. 2025;94:102554.
    PubMed     Abstract available


  56. LOVELL CD, Anguera MC
    More X's, more problems: how contributions from the X chromosomes enhance female predisposition for autoimmunity.
    Curr Opin Immunol. 2025;93:102543.
    PubMed     Abstract available


  57. KRONENBERG M, Riffelmacher T
    Defenders or defectors: mucosal-associated invariant T cells in autoimmune diseases.
    Curr Opin Immunol. 2025;93:102542.
    PubMed     Abstract available


  58. SOWERBY JM, Rao DA
    T cell-B cell interactions in human autoimmune diseases.
    Curr Opin Immunol. 2025;93:102539.
    PubMed     Abstract available


    January 2025
  59. HAO K, Marshak-Rothstein A
    Nucleic acid triggers of autoimmunity and autoinflammation.
    Curr Opin Immunol. 2025;93:102535.
    PubMed     Abstract available


    December 2024
  60. HARM J, Fan YT, Brenner D
    Navigating the metabolic landscape of regulatory T cells: from autoimmune diseases to tumor microenvironments.
    Curr Opin Immunol. 2024;92:102511.
    PubMed     Abstract available


    September 2024
  61. HAMERMAN JA, Barton GM
    The path ahead for understanding Toll-like receptors-driven systemic autoimmunity.
    Curr Opin Immunol. 2024;91:102482.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum